Balsalazide|cas 80573-04-2|DC Chemicals

Balsalazide|cas 80573-04-2|DC Chemicals

Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.

IC50:

Target: Others

Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug.

Product Name: Balsalazide|Cat No: DC9562|Cas: 80573-04-2|Molecule Formular: C17H15N3O6|Molecule Weight: 357.3175|Other names: Balsalazide


Balsalazide is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease.
Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug. High dose balsalazide (3.0 g twice daily) was superior in maintaining remission in patients with ulcerative colitis compared with a low dose (1.5 g twice daily) or a standard dose of mesalazine (0.5 g three times daily). All three treatments were safe and well tolerated. Balsalazide is approved for the treatment of mild-to-moderate active UC. It is efficacious for the induction of remission in mild to moderate UC and has a favorable safety profile, with the added advantages of greater efficacy of remission induction and rapidity of onset.

For research only, not for human use!